Explore evidence

89 %Of the 183 index clients, 89% accepted Partner Notification services and elicited 216 sexual partners for tracing.

KenyaVIH/sidaobserved January 2017 to August 2018published 2020BMC infectious diseasesPubMeddocument of 6 observations

1.82 AORHIV-positive individuals had adjusted odds ratio of 1.82 for receiving an Xpert® test compared to HIV-negative individuals in Kenya in 2015.

Kenyatuberculose · VIH/sidaobserved 2015published 2018BMC infectious diseaseseurope_pmcdocument of 12 observations

1,512 participantsFrom May 2022 to December 2023, 1,512 participants completed willingness-to-pay questionnaires for online HIV pre- and post-exposure prophylaxis in Nairobi, Kenya.

KenyaVIH/sidaobserved May 2022 to December 2023published 2025BMC health services researchPubMeddocument of 5 observations

0.23 odds_ratioIn the secondary analysis, intervention adolescent girls and young women (AGYW) had fewer symptoms of anxiety than control AGYW, with an odds ratio of 0.23 (95% CI 0.05 to 1.11; p=0.07).

KenyaVIH/sidapublished 2026BMJ global healthPubMeddocument of 9 observations

311 casesOf 2113 participants, 311 (15%) were HIV infected and on antiretroviral therapy.

KenyaVIH/sidapublished 2022The Journal of infectious diseasesPubMeddocument of 4 observations

12.2 %HIV prevalence among female sex workers less than 25 years of age in Nairobi decreased to 12.2% in 2010–2011.

KenyaVIH/sidaobserved 2010–2011published 2021AIDS (London, England)PubMeddocument of 13 observations

8.7 %In scenario 2, waiting time at the testing site accounted for 8.7% of total turnaround time for HIV viral load monitoring.

KenyaVIH/sidapublished 2024Health policy and planningPubMeddocument of 15 observations

45.3 %Of 397 MSM and transgender women enrolled in HPTN 075 across four sites in sub-Saharan Africa, 45.3% (180/397) reported one or more healthcare-related stigma experiences.

KenyaVIH/sidapublished 2020AIDS carePubMeddocument of 4 observations

17 casesOf the 128 participants with genotypes available at timepoint 1, 17 died before timepoint 2.

KenyaVIH/sidapublished 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 13 observations

50 %In 2015, 50% of 1.2 million HIV-exposed infants (HEI) in 21 priority countries received a virologic test within the recommended 2 months of birth.

KenyaVIH/sidaobserved 2015published 2021BMC public healthPubMeddocument of 11 observations

55.7 %The proportion of vitamin D deficiency was 55.7% among HAART-experienced participants.

KenyaVIH/sidapublished 2024BMC infectious diseasesPubMeddocument of 10 observations

20 %Perinatal HIV transmission in Kenya declined from 20% to 10% between 2010 and 2017.

KenyaVIH/sidaobserved 2010 to 2017published 2024PLoS medicineeurope_pmcdocument of 5 observations

65 %Of those screened for PrEP eligibility, 65% of adolescent girls and young women (AGYW) were ineligible.

KenyaVIH/sidaobserved February 2017 to December 2019published 2020Journal of the International AIDS SocietyPubMeddocument of 13 observations

20 %La fréquence de la neuropathie périphérique était de 20 % chez les personnes vivant avec le VIH au Kenya selon l'étude de Cettomai D et al (2010).

KenyaVIH/sidaobserved 2010HAL · Unilimdocument of 747 observations

0.48 hazard_ratioEarly post-operative infection was associated with delayed healing in both HIV-positive and HIV-negative men (HR 0.48, 95% CI 0.23–1.00).

KenyaVIH/sidapublished 2013PloS oneeurope_pmcdocument of 6 observations

8.9 adjusted_odds_ratioDiscontinuing antiretroviral treatment for 2 weeks or more significantly increases the risk of ART failure, with an adjusted odds ratio of 8.9.

KenyaVIH/sidapublished 2017African Journal of Health SciencesOpenAlexdocument of 8 observations

2.09 aPRMale partner controlling behavior was significantly associated with a higher prevalence of intimate partner violence in the past year among women with HIV in serodifferent relationships in Nairobi, Kenya, with an adjusted prevalence ratio of 2.09.

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 8 observations

193.3 EU/mLOne month post dose 3, anti-CS geometric mean antibody concentrations were 193.3 EU/mL in RTS,S/AS01-vaccinated HIV-infected children.

KenyaVIH/sidapublished 2020Vaccineeurope_pmcdocument of 7 observations

87.5 %Serious adverse events were reported for 87.5% of HIV-infected children in the C3C group.

KenyaVIH/sidapublished 2020Vaccineeurope_pmcdocument of 7 observations

4.5 %Men in Kenya have an HIV prevalence rate of 4.5%.

KenyaVIH/sidapublished 2025AIDS research and therapyPubMeddocument of 6 observations

650.6 cells/mm3The median CD4 cell count was 650.6 cells/mm3 among HIV-infected adolescents and young adults aged 10–24 years attending Kenyatta National Hospital comprehensive care center.

KenyaVIH/sidapublished 2021African health sciencesPubMeddocument of 5 observations

0.46 %Of facility-records with reporting data, 0.46% were retained for blood safety programmatic area reports.

KenyaVIH/sidapublished 2020BMC medical informatics and decision makingPubMeddocument of 5 observations

40 %Of 96 youth living with HIV in Kenya, 40% acquired HIV perinatally.

KenyaVIH/sidapublished 2021AIDS and behaviorPubMeddocument of 13 observations

77 %Willingness to use mobile phones for HIV services was 77% among those who had individual phone access and 18% among those who shared a phone.

KenyaVIH/sidapublished 2022International journal of medical informaticsPubMeddocument of 7 observations

34 %Among 19,427 HIV clients at eight facilities in Homa Bay County, Kenya, 6,649 (34%) had a CD4 count < 200 cells/mm³ or WHO clinical stage III/IV.

KenyaVIH/sidaobserved October 2016 to September 2019published 2023MedicinePubMeddocument of 14 observations